Company Filing History:
2 out of 64 
2 out of 101 Years Active: 2017-2018
Title: Ram Eitan: Innovator in Ovarian Cancer Prognosis
Introduction
Ram Eitan is a notable inventor based in Einat, Israel. He has made significant contributions to the field of medical research, particularly in the prognosis of ovarian cancer. With a total of 2 patents, Eitan's work focuses on innovative methods and compositions that enhance the understanding and treatment of this critical health issue.
Latest Patents
Eitan's latest patents include groundbreaking compositions and methods for the prognosis of ovarian cancer. These inventions describe innovative approaches for predicting the prognosis of ovarian cancer subjects. The patents provide methods for distinguishing between histological subtypes of ovarian cancer tumors. Furthermore, they offer compositions and methods for the treatment or prevention of ovarian cancer. Specifically, the inventions relate to microRNA molecules associated with these methods and compositions, as well as various nucleic acid molecules related to or derived from them.
Career Highlights
Throughout his career, Ram Eitan has worked with prominent companies in the biotechnology sector. He has been associated with Rosetta Genomics Ltd. and Mor Research Applications Ltd. These experiences have allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Some of Eitan's notable coworkers include Gila Lithwick Yanai and Moshe Hoshen. Their collaborative efforts have further enriched the research environment and fostered innovation in the field of ovarian cancer prognosis.
Conclusion
Ram Eitan's contributions to the field of ovarian cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative approaches continue to pave the way for advancements in medical science.